Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 7Unknown 5Recruiting 2Suspended 1Active not recruiting 1

Sponsor Class

OTHER 71OTHER_GOV 2FED 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1CNS 1

Conditions

Motor Activity 1Medulloblastoma 1Endometrial Neoplasms 1

Interventions

Drug Therapy 10pembrolizumab 9Bevacizumab 9Radiotherapy 8Cyclophosphamide 8Carboplatin 8Oxaliplatin 7tislelizumab 6Surgical Procedures, Operative 6Docetaxel 6Cisplatin 6Capecitabine 6Paclitaxel 5Nivolumab 5Fluorouracil 5Control Groups 5fludarabine 4Immune Checkpoint Inhibitors 4Gemcitabine 4Endoscopic Mucosal Resection 4sintilimab 3Trastuzumab 3Pemetrexed 3Neoadjuvant Therapy 3Leucovorin 3Laparoscopy 3Irinotecan 3Injections 3Hematologic Tests 3HMPL-013 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER_GOV × Exercise × Clear all
NCT06898684 2025-12-16

MOVE

Vastra Gotaland Region

Phase NA Recruiting
15 enrolled
CNS

Medulloblastoma, Motor Activity

NCT07025213 2025-06-17

Metabolic Effect of Exercise and Diet in Endometrial Cancer Patients Eligible for Staging Surgery.

National Institute of Cancerología

Phase NA Recruiting
80 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡